SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-008008
Filing Date
2019-06-14
Accepted
2019-06-14 16:40:35
Documents
6
Period of Report
2019-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fcsc61419form8-k.htm 8-K 78098
2 EXHIBIT 10.1 ex101fibrocellscience2019e.htm EX-10.1 123731
3 EXHIBIT 10.2 ex102fibrocellisograntee.htm EX-10.2 33665
4 EXHIBIT 10.3 ex103fibrocellnqgrantee.htm EX-10.3 29452
5 EXHIBIT 10.4 ex104fibrocellnqgrantdirec.htm EX-10.4 27620
6 image0a37.jpg GRAPHIC 74382
  Complete submission text file 0001628280-19-008008.txt   393996
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31564 | Film No.: 19899413
SIC: 2834 Pharmaceutical Preparations